Two fragments were identified and synthesized: a fragment responsible for binding to TNFR1 and inhibiting cytotoxicity (it was designated 17.1A) and a peptide fragment with a high affinity for Hsp70, which is involved in the killing of tumor cells (17.1B) [19]. Here, TNFRSF1A is linked to neoplasm.